A comparison of thoracoscopic talc insufflation, slurry, and mechanical abrasion pleurodesis.
The purpose of this study was to compare the anatomic and histopathologic results of four different methods of pleurodesis in 10 dogs. Each animal was randomly assigned to receive two of the following methods of pleurodesis: thoracoscopic talc insufflation (poudrage), talc slurry administration, focal gauze abrasion by limited thoracotomy, and mechanical abrasion by thoracoscopy using a commercially available pleural abrader. Animals were killed 30 days after pleurodesis. At autopsy, the efficacy of pleurodesis was graded by evaluating the gross appearance of each pleural cavity and lung (pleurodesis score), and by determining the extent of adhesion formation (obliteration grade). Pleural and lung biopsy specimens were obtained from the areas most representative of adhesion formation for histopathologic evaluation. Pleurodesis scores (on a scale of 0 to 4) were 3.0 +/- 0.7 for talc poudrage (p < 0.05 when compared with talc slurry), 2.2 +/- 1.7 for thoracotomy, and 1.6 +/- 1.1 for talc slurry. Adhesions produced by gauze abrasion during thoracotomy were mostly peri-incisional. Thoracoscopic pleural abrasion using the pleural abrader was uniformly unsatisfactory. Granulation tissue formation was greatest in both talc models. The degree of parietal pleural thickening was greatest in the talc slurry model, but fibrosis and inflammation occurred mostly in gravity-dependent areas within the pleural cavity. Although differences were not statistically significant, thoracoscopic talc insufflation consistently produced the most widespread, firm fibrotic adhesions as evidenced by higher obliteration grades.
Colt
H G
HG
Division of Pulmonary and Critical Care Medicine, University of California San Diego 92103, USA.
Russack
V
V
Chiu
Y
Y
Konopka
R G
RG
Chiles
P G
PG
Pedersen
C A
CA
Kapelanski
D
D
D000818:Animals; D004285:Dogs; D010994:Pleura / Q000473:pathology; D018700:Pleurodesis / Q000379:methods*; D013627:Talc / Q000008:administration & dosage* / Q000627:therapeutic use; D013906:Thoracoscopy; D000267:Tissue Adhesions
D013627:Talc